Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)A D Roth, R Maibach, G Martinelli, et al.
ACS Applied Materials & Interfaces|May 11, 2019
Amino Acid-Functionalized Polyelectrolyte Films as Bioactive Surfaces for Cell AdhesionM S Leal, X Briones, V Villalobos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaW Weder, R A Stahel, J Bernhard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2014
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical featuresE Missiaglia, B Jacobs, G D'Ario, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2015
Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trialN Fazio, R Biffi, R Maibach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)D Koeberle, J-F Dufour, G Demeter, et al.
British Journal of Cancer|April 20, 2006
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyD C Betticher, S-F Hsu Schmitz, M Tötsch, et al.
Pageof 4